Patient-Centered Outcomes Research Institute
Strategies to Prevent Unsafe Opioid Prescribing in Primary Care among Patients with Acute or Chronic Noncancer Pain – Cycle 2 2017
- What do you mean by “powering the study for subgroups of interest”?
- Although Letters of Support are not required at the LOI stage, do applicants need to confirm all study sites, especially if one is choosing between a few but needs to have more time regarding visibility and buy-in?
- Medical side effects of treatment are listed as a potential key outcome. Does this mean side effects of the comparators being evaluated, or does it mean side effects of opioid therapy?
- What types of observational studies would PCORI be interested in for this PFA?
- If the strategy we are evaluating includes multiple components (e.g., profiling and educational interventions and expansion of services), is it responsive to the first research question if it also includes an element of shared decision making?
- What is considered to be in "widespread use"?
- Is complementary and alternative medicine considered within scope as a strategy for enhancing alternatives to opioids for pain management?
- What is PCORI's definition of primary care? Would this include obstetrics and gynecology?
- What is PCORI's definition of unsafe prescribing?
- Must strategies aim to both ensure access to non-opioid methods for pain management and prevent unsafe prescribing?
- Is there a minimum amount on the awards that will be issued? Does PCORI support focused projects that request a lesser amount of funding?
- Must study interventions be currently billable/insurance-reimbursable services?
- Can PCORI funding be used to hire a therapist/yoga instructor for the project to deliver the study interventions to patients?
- What is PCORI's definition of a healthcare system in relation to this funding announcement?
- May our proposed study address both of the priority research questions?
- Letter of Intent
- Application
- Budget
- Can the study partner be a payer?
- Can the study partner be a federal agency?
- Are patients from other countries allowed to participate in the study?
- Does PCORI allow for sites within the United States to work closely as partners with sites outside of the United States?
- Are researchers who are not affiliated with an organization eligible to apply?
- Where can I get technical assistance related to application submission issues?
- May I contact someone at PCORI about the suitability of my proposed project?
- What is the purpose of the Study Advisory Committee (SAC)?